What Are The Chances Of Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Becoming A Clear Buy?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Stocks Info

As a NYSE listed company, TEVA falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Teva- Pharmaceutical Industries Ltd. ADR is $17.75B. A total of 6.24 million shares were traded on the day, compared to an average of 12.25M shares.

In the most recent transaction, Daniell Richard sold 70,961 shares of TEVA for 15.91 per share on Mar 05 ’25. After the transaction, the Exec. VP, European Commercial now owns 48,384 company shares. In a previous transaction on Mar 04 ’25, Hughes Eric A sold 15,174 shares at 15.73 per share. TEVA shares that See “Remarks” owns now total 8,077.

Among the insiders who sold shares, Hughes Eric A disposed of 8,077 shares on Mar 05 ’25 at a per-share price of $15.91. This resulted in the See “Remarks” holding 0 shares of TEVA after the transaction. In another insider transaction, Daniell Richard sold 91,608 shares at $15.73 per share on Mar 04 ’25. Company shares held by the Exec. VP, European Commercial now total 7,108.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, TEVA has a high of $22.80 and a low of $12.51.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. TEVA’s latest balance sheet shows that the firm has $2.17B in Cash & Short Term Investments as of fiscal 2021. There were $23.46B in debt and $11.03B in liabilities at the time. Its Book Value Per Share was $4.74, while its Total Shareholder’s Equity was $11.24B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TEVA is Buy with a score of 4.75.

Most Popular

Related Posts